Advertisement

Topics

Samsung Bioepis and Takeda enter biologics co-development deal

15:40 EDT 23 Aug 2017 | Elsevier Business Intelligence

Samsung Bioepis Co. Ltd., a joint venture formed by Samsung BioLogics and Biogen Inc., and Takeda Pharmaceutical Co. Ltd. ent...

Original Article: Samsung Bioepis and Takeda enter biologics co-development deal

NEXT ARTICLE

More From BioPortfolio on "Samsung Bioepis and Takeda enter biologics co-development deal"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...